Home | Services | Products | Support | Useful Documents | Experience | Staff | Opportunities
	News Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of calcitonin gene-related peptide antagonists for the prevention of migraine eSYS Development contracted with the Royal Australasian College of Surgeons to assess deep brain stimulation of the thalamus for the treatment of severe refractory epilepsy for MSAC in Australia Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of treatment of hypercholesterolemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of vertebroplasty or kyphoplasty in patients with symptomatic osteoporotic vertebral compression fractures Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of long-term physiotherapy in patients after stroke, with multiple sclerosis, or with Parkinson’s disease Ross McLeod joins World Health Organization Technical and Scientific Advisory Group on the Development of Target Product Profiles (TPPs) for Snake Antivenom Products Annual Costs of Feral Deer in Australia     Latest News       Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of treatment of hypercholesterolemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines   The aim of the Health Technology Assessment (HTA) is to evaluate the efficacy, safety, cost-effectiveness, and budgetary impact of ezetimibe-containing medicines compared to statins or fenofibrate in patients with hypercholesterolaemia or mixed/combined hyperlipidaemia. https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/ezetimib.html Previous News Next News